Status:
COMPLETED
Pro-thrombotic Status in Patients with SARS-Cov-2 Infection
Lead Sponsor:
University Hospital of Ferrara
Conditions:
Severe Acute Respiratory Syndrome Coronavirus 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The present study is ideated to prospectively investigate in patients with severe acute respiratory syndrome (SARS) due to Coronavirus 19 (SARS-Cov-2) infection and moderate-severe respiratory failure...
Detailed Description
Preliminary evidences suggested that patients with SARS-Cov-2 infection and concomitant presence of cardiovascular risk factors (i.e. arterial hypertension) and/or cardiovascular history (i.e. prior m...
Eligibility Criteria
Inclusion
- Diagnosis of moderate-severe respiratory failure (PaO2/FiO2 \<200)
- Diagnosis of SARS-CoV-2 infection + one of the following
- invasive mechanical ventilation (cohort A)
- non invasive mechanical ventilation (cohort B)
- only oxygen support
Exclusion
- Previous chronic use of P2Y12 inhibitors
- Need for chronic oral anti-coagulation therapy
- Know disorder of coagulation or platelet function
Key Trial Info
Start Date :
April 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 7 2024
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT04343053
Start Date
April 8 2020
End Date
December 7 2024
Last Update
December 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria di Ferrara
Ferrara, Italy